Legal & Compliance
As part of the Terumo group, Terumo Neuro adheres to AdvaMed guidance, including the AdvaMed Code of Conduct on Interactions with U.S. Health Care Professionals. To learn more about AdvaMed and the Code of Ethics, please visit the AdvaMed website at the link below:
Terumo Neuro expects its associates and business partners to act ethically and in accordance with all applicable laws and industry codes.
We have a global Helpline, www.terumointegrity.com, where good faith concerns about the conduct or practices of Terumo Neuro, its associates, or business partners may be reported. The telephone number to reach our Helpline varies from country to country. This confidential tool makes it easy to report, day or night, and is accessible via phone or internet.
Terumo Neuro also allows reporting to:
1. any manager
2. to Human Resources
3. to a Company Executive
4. the General Counsel or any other Company attorney
5. the Company Compliance Officer or Compliance Partner
Terumo Neuro will take appropriate action, in its sole determination, in response to each report and the nature and extent of each action will depend, in part, on the nature of the concern.
Terumo Neuro prohibits harassment of, or retaliation against, any associate or other person who reports in good faith a known or suspected violation of law or of Terumo Neuro policies.
Helpline Country Numbers:
Argentina: 0800-222-4417
Australia: 1-300-027-655
Austria: 0800-802708
Belgium: 0800-745-44
Brazil: 0-800-591-6017
Canada: 1-800-205-654
Chile: 800-914-389
China(400-1):400-120-9159
Colombia: 01800-710-2015
Costa Rica: -40014640
Denmark: 8082-0309
Finland: 0800-915-764
France: 0805-080232
Germany: 0800-180-6591
Hong Kong: 800-906-073
India: 000-800-100-4152
Indonesia: 001-803-015-203-9782
Ireland: 1-800-902-285
Italy: 800-136-850
Japan: 0800-222-0399
Korea: 080-808-0962
Malaysia: 1-800-817-793
Mauritius: 720-904-7205
Mexico: 01-800-099-0687
Panama: 507-8338992
Peru : 0800-78341
Philippines: 63-2-2312143
Poland: 0-0-800-141-0263
Portugal: 800-180-437
Puerto Rico: 1-800-210-8757
Russia: 8-800-100-9684
Scotland: 0-808-189-0972
Singapore: 800-852-6118
South Africa: 0-800-993-054
Spain: 900-839236
Sweden: 020-889-218
Switzerland: 0800-893-904
Taiwan, R.O.C.: 00801-85-6728
Thailand: 001-800-852-5417
Turkey: 90-850-7661495
UAE: 8000-3570-3914
United Kingdom: 0-808-189-0972
United States: 1-800-261-9347
Uruguay: 000-416-205-6405
Venezuela: 0-800-102-9418
Vietnam: (122): 122-80-354Terumo Neuro considers requests for: education grants, research grants to support genuine independent medical research for the advancement of medical science, and donations for charitable purposes to charitable entities. All grant and donation requests will be reviewed by the Grants and Donations Committee. Sales and Marketing associates are not involved in the grant and donation review process and requests for follow-up or additional information should not be directed to these associates.
North America, Latin America and Asia Pacific
If you are a healthcare professional or healthcare organization located in North America, Latin America, or Asia Pacific and desire to request a grant or donation from Terumo Neuro, please submit your request to Terumo Neuro at MVGrantCommittee@microvention.com using the appropriate application form available for download below. Please attach to your submission email any additional information required by the form. If the request relates to independent research, please attach a copy of the protocol. All materials and letters must be submitted in English.
- Educational Grant Application Form
- Investigator Initiated Study Research Grant Application Form
Terumo Neuro complies with the US Federal Open Payments Act (also known as Sunshine Law) (Section 6002 of the Patient Protection and Affordable Care Act (Public Law No. 111-148), as amended by the Health Care and Education Reconciliation Act of 2010 (Public Law No. 111-152).
Open Payments is a federal program, required by the Affordable Care Act, that collects information about the payments drug and device companies make to physicians and teaching hospitals for things like travel, research, gifts, speaking fees, and meals. It also includes ownership interests that physicians or their immediate family members have in these companies. This data is then made available to the public each year on this website. More information about Open Payments can be found at https://www.cms.gov/openpayments/.
If you have questions about Terumo Neuro’s reporting under this law, please contact ussunshine@microvention.com.
This information is provided pursuant to the requirements of California Health & Safety Code § 119402, which requires certain pharmaceutical and medical device companies doing business in California to make available their program for compliance with applicable federal and state laws and industry standards regulating the marketing and promotion of their products.
ANNUAL DESCRIPTION OF COMPREHENSIVE COMPLIANCE PROGRAM CALIFORNIA HEALTH & SAFETY CODE §§ 119400-119402.
Terumo Neuro is committed to doing business in accordance with the highest standards of business conduct and ethics. We consider our reputation for ethical and compliant behavior to be a valuable corporate asset. Each employee of Terumo Neuro is charged with the responsibility for safeguarding and strengthening that asset.
Terumo Neuro is dedicated to complying with U.S. federal and state laws and regulations that place certain restrictions and reporting requirements on interactions that Terumo Neuro has with U.S. health care professionals and related organizations. Most notably, the Federal Physician Payment Sunshine Act requires Terumo Neuro to annually report to the U.S. Centers for Medicare and Medicaid Services information about payments and other transfers of value that are provided to U.S. physicians and teaching hospitals. Payment types that are subject to reporting under this transparency law may include consulting fees, meals, travel, charitable donations, payments related to clinical trials and research, and physician educational materials. Terumo Neuro is committed to fulfilling its obligations to track and report these payments and transfers of value as required by U.S. law.
In addition to complying with its obligations under U.S. federal and state transparency laws, Terumo Neuro has established a Compliance Program in accordance with California Health and Safety Code, Division 104, Part 15, Chapter 8, Sections 119400‐119402 (the "Statute"), based on our good faith understanding of the requirements of the Statute as it may apply to a medical device manufacturer. Terumo Neuro has developed a Compliance Program consistent with the Compliance Program Guidance for Pharmaceutical Manufacturers (which is expressly applicable to medical device manufacturers) published by the Office of Inspector General of the U.S. Department of Health and Human Services. Our Compliance Program is tailored to the size, organizational structure, nature of our business as a medical device manufacturer and resources of Terumo Neuro. Terumo Neuro's Compliance Program is designed to comply with the AdvaMed Code of Ethics on Interactions with Health Care Professionals (the "AdvaMed Code"). The AdvaMed Code is a voluntary ethical code established by the medical device industry. It is substantially similar to the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals, but reflects the unique interactions between medical device manufacturers and health care professionals. Further, as required by the Statute, Terumo Neuro has an annual limit on promotional spending.
While adoption of appropriate policies do not necessarily guarantee that improper individual conduct will be entirely eliminated, it is Terumo Neuro's expectation that our associates comply with our Code of Conduct, Comprehensive Corporate Compliance Program, Code of Ethics on Interactions with Healthcare Professionals and other policies and/or procedures as adopted from time to time in support of the AdvaMed Code. Furthermore, our Compliance Program has been designed to prevent and detect violations. In the event Terumo Neuro becomes aware of potential violations of law or Terumo Neuro policy, Terumo Neuro will, as appropriate, take action which may include investigating the matter, taking disciplinary action, and/or implementing corrective measures to prevent future violations. Terumo Neuro periodically reassesses the Compliance Program to improve it, and may refine the elements as necessary.
To obtain information about Terumo Neuro's Compliance Program and/or written declaration of compliance, please call 1-800-990-8368 and ask for the Compliance Department.
The California Transparency in the Supply Chains Act of 2010 requires certain manufacturers and retailers, including Terumo Neuro, to disclose their efforts to eradicate human trafficking and slavery from their supply chains. At this time, Terumo Neuro does not independently verify its product supply chain or its direct suppliers for risks relating to human trafficking or slavery, nor for compliance with Terumo Neuro standards. Similarly, Terumo Neuro does not require its suppliers to certify that they comply with the laws of the countries in which they are doing business. Terumo Neuro does not provide its employees with training on human trafficking or slavery, nor does it maintain internal accountability standards or procedures related to the same.